Advertisement

Pulmonary Infections

  • Jonathan E. Rodnick
  • James K. Gude

Abstract

Acute bronchitis is a self-limited inflammation of the trachea and bronchi. It is common in smokers and occurs frequently during the winter months. In the United States bronchitis accounts for about 12 million physician visits a year and more than $300 million in physician visits and prescriptions. Work absences are common and probably run into millions of days each year. Much of this disability is due to acute flare-ups of chronic bronchitis, which is not discussed in this section.

Keywords

Tuberculin Skin Test Lower Respiratory Tract Infection Pneumocystis Carinii Pneumonia Mycoplasma Pneumoniae Acute Bronchitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Williamson HA. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 1987;25: 251–6.PubMedGoogle Scholar
  2. 2.
    Strope GL, Stewart PW, Henderson FW. Lung function in school-age children who had mild lower respiratory illness in early childhood. Am Rev Respir Dis 1991;144:655–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Franks P, Gleiner JA. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract 1984; 19:185–90.PubMedGoogle Scholar
  4. 4.
    Dunlay J, Reinhardt R, Roi LD. A placebo-controlled double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 1987;25:137–41.PubMedGoogle Scholar
  5. 5.
    Rodnick JE, Gude JK. The use of antibiotics in acute bronchitis and acute exacerbations in chronic bronchitis. West J Med 1988;149:347–51.PubMedGoogle Scholar
  6. 6.
    Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine (Baltimore) 1990;69:307–16.Google Scholar
  7. 7.
    British Thoracic Society Research Committee. Community acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcomes. Q J Med 1987;62:195–220.Google Scholar
  8. 8.
    Rodnick JE, Gude JK. Diagnosis and antibiotic treatment of community-acquired pneumonia. West J Med 1991;154:405–9.PubMedGoogle Scholar
  9. 9.
    Fine MJ, Smith DJ, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 1990;89:713–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115:428–36.PubMedCrossRefGoogle Scholar
  11. 11.
    Sanford JP. Guide to antimicrobial therapy 1992. Dallas: Antimicrobial Therapy, Inc., 1992:23–26.Google Scholar
  12. 12.
    Steinhoff MC, Auerbach BS, Nelson MD, et al. Antibody responses to Haemophilus influenza type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991; 325:1837–42.PubMedCrossRefGoogle Scholar
  13. 13.
    Mansel JR, Rosenow EC, Smith TF, Martin JW. Myoplasma pneumoniae pneumonia. Chest 1989;95:639–46.PubMedCrossRefGoogle Scholar
  14. 14.
    Grayston JT. Chlamydia pneumoniae, strain TWAR. Chest 1989; 95:664–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Atmar RL, Greenberg SB. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Semin Respir Infect 1989;4: 19–31.PubMedGoogle Scholar
  16. 16.
    Cunha BA. Atypical pneumonias: clinical diagnosis and treatment. Postgrad Med 1991;90:89–101.PubMedGoogle Scholar
  17. 17.
    David GS, Winn WC. Legionnaire’s disease: respiratory infections caused by Legionella bacteria. Clin Chest Med 1987;8:419–39.Google Scholar
  18. 18.
    Keys TF. Therapeutic considerations in the treatment of Legionella infections. Semin Respir Infect 1987;2:270–3.PubMedGoogle Scholar
  19. 19.
    Saag MS, Dismukes WE. Treatment of histoplasmosis and blastomycosis. Chest 1988;93:849–51.CrossRefGoogle Scholar
  20. 20.
    Salzman SH, Smith RL, Aranda CP. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest 1988;93:916–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Hedges E, Miller S. Coccidioidomycosis: office diagnosis and treatment. Am Fam Physician 1990;41:1499–1506.PubMedGoogle Scholar
  22. 22.
    Dowling PT. Return of tuberculosis: screening and preventive therapy. Am Fam Physician 1991;43:457–67.PubMedGoogle Scholar
  23. 23.
    American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986;134:355–63.Google Scholar
  24. 24.
    Mehta JB, Morris F. Impact of HIV infection on mycobacterial disease. Am Fam Physician 1992;45:2203–11.PubMedGoogle Scholar
  25. 25.
    Rodnick JE. New guidelines for tuberculin skin test interpenetration. West J Med 1991;154:322–3.PubMedGoogle Scholar
  26. 26.
    Goldschmidt RH, Dong BJ. Treatment of AIDS and HIV-related conditions: 1992. J Am Board Fam Pract 1992;5:335–50.Google Scholar
  27. 27.
    Riskin J, LaRiviere M. Low dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991;337:468–71.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Jonathan E. Rodnick
  • James K. Gude

There are no affiliations available

Personalised recommendations